Kay Yuen-Ki Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kay Yuen-Ki Wong has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Kelvin Sze-Yin Leung
Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, People’s Republic of China
1 shared publication - Patrick Ying-Kit Yue
Department of Biology, Hong Kong Baptist University, Hong Kong, China
1 shared publication Yeuk-Ki Tsoi
Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Kowloon, Hong Kong SAR, China
1 shared publication- Yi-Yi Wong
Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong, SAR, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Springer Nature in Chinese Medicine
- Vol. 8 (1) , 21
Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea
Antrodia cinnamomea (AC) is an endemic mushroom species of Taiwan, and has been demonstrated to possess diverse biological and pharmacological activities, such as anti-hypertension, anti-hyperlipidemia, anti-inflammation, anti-oxidation, anti-tumor, and immunomodulation. This review focuses on the inhibitory effects of AC on hepatitis, hepatocarcinoma, and alcohol-induced liver diseases (e.g., fatty liver, fibrosis). The relevant biochemical and molecular mechanisms are addressed. Overall, this review summarizes the hepatoprotective activities in vitro and in vivo. However, there is no doubt that human and clinical trials are still limited, and further studies are required for the development of AC-related products.
- 1 January 2013
- Published by Springer Nature in Chinese Medicine
- Vol. 8 (1) , 21
Open AccessCurrent evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea
Antrodia cinnamomea (AC) is an endemic mushroom species of Taiwan, and has been demonstrated to possess diverse biological and pharmacological activities, such as anti-hypertension, anti-hyperlipidemia, anti-inflammation, anti-oxidation, anti-tumor, and immunomodulation. This review focuses on the inhibitory effects of AC on hepatitis, hepatocarcinoma, and alcohol-induced liver diseases (e.g., fatty liver, fibrosis). The relevant biochemical and molecular mechanisms are addressed. Overall, this review summarizes the hepatoprotective activities in vitro and in vivo. However, there is no doubt that human and clinical trials are still limited, and further studies are required for the development of AC-related products.